Rapamycin Study Could Transform Aging in Older Adults
Large rapamycin clinical trial launches at UT Health San Antonio - UT Health San Antonio
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
UT Health San Antonio has launched a major National Institute on Aging-funded clinical trial testing rapamycin, an immunosuppressant drug traditionally used to prevent organ transplant rejection. The study will investigate how rapamycin can promote healthy aging in older adults. This research could unlock new therapeutic applications beyond its current transplant medicine uses.
Original Article
Read full article on sourceExplore More
Related News
Op-Ed: We all need public health. Public health needs you. — Waterbury Roundabout
Waterbury Roundabout · 2026.04.14
Balochistan s failing health
The Express Tribune · 2026.04.14
Perspectives on Health Data Sharing Among Patients With Somatic and Mental Health Diseases: Focus Group Study
2026.04.14
Murray students explore health careers at Mercy Health
The Paducah Sun · 2026.04.14
Girls Health Day to educate young women on health, social issues
https://www.fox8live.com · 2026.04.14
For Your Health — What to Know About GLP-1 Drugs for Weight Loss and Health
Wayne County Journal Banner · 2026.04.14